Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation.
about
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction.Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.Ipilimumab in melanoma.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.Immune checkpoint inhibitors in challenging populations.Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.Renal complications of immune checkpoint blockade.Biomarkers in hepatocellular carcinoma: an overview.Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma.Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma.Anti-PD-1 monotherapy versus anti-PD1 plus anti-CTLA4 in advanced melanoma: how do we decide?Checkpoint inhibitor use in two heart transplant patients with metastatic melanoma and review of high-risk populations
P2860
Q37346073-8DD88CD1-48EC-47DC-BE83-2B735221188CQ37346118-E2417301-9D41-4EEC-9558-3571C61B7BC3Q38586991-3C181D1B-6CDA-4C2C-B250-6CD7293753E0Q38844500-E4617742-0370-4A80-87A1-BA997F60C0B1Q38893697-83CFA365-64F2-4343-9EFB-B89BBED04AA4Q38918124-2D307ED5-173D-4AC1-9675-D1EFF93D26E1Q38930084-8A0CDFB3-1C63-4ECA-9A2F-4C99A6C3D919Q38939708-F06C9783-EBBC-40A3-9ABA-3C0611D337BBQ39009781-9C9C5C81-E3AB-4A97-97D1-D6BDF6DC943DQ39131602-470B8F4B-0044-4432-B833-EC7672703237Q39202758-382E352E-EEB4-4553-9D60-BBAE268845B6Q40148698-36F899CC-A6C6-4706-9B19-32277914AAEDQ46151780-0965639C-D6FA-439E-9636-534064090F4BQ56893675-0DE449C2-AF20-462A-AC33-1F0E4470EFF1Q59135661-F824BA5E-BB1C-4860-89EF-247B711DDF74
P2860
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@en
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@nl
type
label
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@en
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@nl
prefLabel
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@en
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@nl
P2093
P2860
P1476
Safety and efficacy of ipilimu ...... ting of liver transplantation.
@en
P2093
Evan J Lipson
Michelle M Walsh
Priya Grewal
Richard D Carvajal
Rita E Morales
P2860
P2888
P356
10.1186/S40425-015-0066-0
P577
2015-06-16T00:00:00Z
P5875
P6179
1024585366